Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Qualigen Therapeutics ( (QLGN) ) has provided an announcement.
Qualigen Therapeutics, Inc. has been granted an extension by the Nasdaq Hearings Panel to continue its listing, with a compliance deadline set for November 19, 2024. The company is actively working towards meeting the necessary criteria for its continued presence on The Nasdaq Capital Market. This news, which reflects the company’s current efforts and the potential implications for its future, is vital for investors tracking Qualigen’s compliance journey and its impact on stock performance.
Find detailed analytics on QLGN stock on TipRanks’ Stock Analysis page.